Clinical Trials Logo
  1. Home
  2. Opioid-use Disorder
  3. NCT02861976
  4. Details
NCT02861976 Clinical Trial

Screening in Trauma for Opioid Misuse Prevention

Opioid Use Disorder Clinical Trial

— STOMP  

Official title:
Screening in Trauma for Opioid Misuse Prevention (STOMP): Screen Development and Pilot Implementation Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02861976
Other study ID # 2016-0430
Secondary ID 3152A532050SMPH/
Status Completed
Phase
First received
Last updated
Start date July 15, 2016
Est. completion date June 1, 2020

Study information
Verified date June 2020
Source University of Wisconsin, Madison
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The current study seeks to begin the crucial work of creating effective protocols to prevent opioid misuse, addiction, and related complications by developing and pilot testing an opioid risk screening protocol at Wisconsin trauma centers.

Recruitment information / eligibility
Status Completed
Enrollment 346
Est. completion date June 1, 2020
Est. primary completion date May 23, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Inpatient victim of traumatic injury

- Expected need for post-discharge outpatient opioid analgesia

- English speaking

- Disposition to short-term rehabilitation facility is allowed

Exclusion Criteria:

- Disposition to a skilled nursing or long-term acute care facility

- Current active opioid use disorder or current active participation in a program of recovery for another substance use disorder

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Opioid risk screen development & implementation
Development of a screening tool for the risk of opioid misuse in patients with traumatic injury.

Locations
Country Name City State
United States University of Wisconsin - Madison Madison Wisconsin

Sponsors (1)
Lead Sponsor Collaborator
University of Wisconsin, Madison

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Opioid use disorder (CIDI-SAM) or opioid misuse (COMM) Opioid Use Disorder in 6 Months Post Traumatic Injury This data will be analyzed in tandem with patient demographics, physical and mental health, and hypothesized risk factors for opioid misuse. 6 months subject participation
See also
  Status Clinical Trial Phase
Recruiting NCT06021431 - Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT N/A
Completed NCT06266572 - Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment Phase 1
Recruiting NCT05037682 - Pain and Opioid Management in Older Adults N/A
Completed NCT06200740 - Remotely Observed Methadone Evaluation N/A
Not yet recruiting NCT06441604 - Extended-release Buprenorphine as a Novel Low-dose Induction Strategy Phase 2
Recruiting NCT06028126 - Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial N/A
Completed NCT02559973 - Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder Phase 1
Completed NCT02440256 - Expanded HIV Care in Opioid Substitution Treatment (EHOST) Trial N/A
Completed NCT02593474 - Medication-Assisted Treatment for Youth With Substance Use Disorders Phase 1
Completed NCT05587998 - A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users. Phase 1
Terminated NCT04577144 - An Observational Study of Environmental and Socioeconomic Factors in Opioid Recovery - Long Term
Recruiting NCT06001437 - Following Outcomes Remotely Within Addiction Recovery Domains
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2
Completed NCT05546229 - Assessment of Methadone and Buprenorphine in Interstitial Fluid
Not yet recruiting NCT06104280 - Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment N/A
Not yet recruiting NCT06416020 - Integrating MOUD in African American Community Settings (Better Together) N/A
Recruiting NCT06206291 - Cannabidiol for Opioid Addiction Phase 2
Completed NCT05552040 - START NOW in the Treatment of Opioid Addicted Individuals N/A
Recruiting NCT05459922 - Adjunctive Bright Light Therapy for Opioid Use Disorder N/A
Recruiting NCT05343169 - Community-based Education, Navigation, and Support Intervention for Military Veterans N/A